Expertise and extensive experience have an important place in information about diabetes. But first impressions count too. The experts can miss key experiences when they aren’t coming fresh to a topic.
The Food and Drug Administration surprised almost everyone on March 24 by approving the DexCom STS Continuous Glucose Monitoring System. Even DexCom’s President and CEO Andrew Rasdal seems to have been surprised.